Depression and pre-clinical depression in adolescents Mental and Behavioural Disorders
Conditions
Interventions
Participants are randomised to one of two study arms by specific software. Age, gender and severity of depressive symptoms will be used as stratification variables. Randomization will be conducted blo
Sponsors
Bavarian State Ministry of Health, Care and Prevention (Bayerisches Staatsministerium für Gesundheit, Pflege und Prävention)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Acute depressive symptoms at least in the subclinical range, operationalized by a Patient Health Questionnaire score of =6 (PHQ-9) 2. Aged 13–18 years 3. Informed consent to participate in the study (particularly regarding randomization and data collection) from both participants and their legal guardians 4. Ability to travel to the therapy locations (climbing gym) to attend the interventions once a week 5. Timely availability of one afternoon per week (120 min) (except for official school breaks) 6. Access to digital devices for video or telephone interviews
Exclusion criteria
Exclusion criteria: 1. Adults (age over 18 years) or children (under 13 years) at the time of t0 2. Body Mass Index (BMI) at an age percentile below 10 or above 97, or a BMI of =35 kg/m2 3. Initiation of psychopharmacological medication or a change in active agent of psychopharmacological medication within 6 weeks (or less) prior to the study (initiation of psychopharmacological medication more than 6 weeks prior to the study or dose adjustment of an existing psychopharmacological medication does not constitute an exclusion criterion) 4. Planned inpatient stay (beyond short-term crisis intervention) during the intervention period 5. Physical contraindications to bouldering as determined by a physician (e.g. pregnancy) 6. Doctoral diagnosed psychotic disorders or mania (lifetime prevalence) 7. Substance dependency by medical diagnosis (lifetime prevalence) 8. Non-suicidal self-injurious behavior involving serious injuries that required medical treatment within the past six months 9. Acute suicidality without the ability to conform to a stepped help contract
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The dimensional severity of depression, measured through both self-report and observer-report assessments. The Observer and Self-Assessment Scales for Depression (FBB-DES and SBB-DES) from the DISYPS-III will be used for evaluations by both parents and adolescents at t0 (pre-intervention), t1 (post-intervention IG), t2 (post-intervention CG) and t3 (follow-up 12 months after t1). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Categorical depression diagnosis will be measured with ILF-INTERNAL from DISYPS-III at t0 and t1 2. Health-related quality of life in adolescents will be assessed using the KIDSCREEN-10 through both self-report and observer-report (parents) at t0, t1, t2, and t3 3. Adolescent self-efficacy will be measured using the General Self-Efficacy Scale (SWE) by Jerusalem and Schwarzer through self-report at t0, t1, t2, and t3 4. Suicidal behaviour and thoughts will be assessed using the DISYPS interview and DISYPS self- (DISYPS-SBB) and observer-report questionnaire (DISYPS-FBB) through self-report at t0, t1, t2, and t3 5. Other psychological issues and comorbid symptoms will be assessed through observer-report by parents using the Strength and Difficulties Questionnaire (SQD-Deu) at t0, t1, t2, and t3 6. The cost-effectiveness analysis from a health economic perspective is performed using EQ-5D-Y in the adolescents' self-report and the resource utilization of the FIM-K, which is completed by the parents in the observer-report at t0, t1, t2, and t3 | — |
Countries
Germany
Contacts
Public ContactCarolin;Katharin Donath;Luttenberger
;
Outcome results
None listed